R&D / Scientists

Careers > Teams > Research & Development

Careers > Teams > Research & Development

Research & Development

Research & 
Development

Research & Development

The team

The team

behind our innovations

behind our innovations

If you join our R&D team, you’ll make a real difference for patients by working at the forefront of science and leveraging a broad range of modalities and technologies. Together, we will move our company closer to our vision of a World Free of Pain.

Get ready to become one of our innovators.

Title Location Job category Date posted
Oligonucleotide Design Lead (f/m/d)
Oligonucleotide Design Lead (f/m/d) Various Locations, AT, BE, DE, DK, ES, FR, GB, IE, IT, NL, PT 18 Nov 2026
Various Locations, AT, BE, DE, DK, ES, FR, GB, IE, IT, NL, PT Research & Development 18 Nov 2026
Global Regulatory Strategist (m/f/d)
Global Regulatory Strategist (m/f/d) Various Locations, AT, BE, DE, DK, ES, FR, GB, IE, IT, NL, PT 18 Nov 2026
Various Locations, AT, BE, DE, DK, ES, FR, GB, IE, IT, NL, PT Research & Development 18 Nov 2026

Our approach to R&D

Research & Development is dedicated to identifying, exploring and advancing innovative therapies for diseases with a high unmet medical need. At the heart of this is scientific excellence, cross-functional collaboration and a strong commitment to translate new therapeutic approaches into real-world impact.

A particular focus is on understanding the biological mechanisms behind pain and related diseases. Based on our industry-leading expertise in the pathophysiology of pain, sensory biology and neuronal health, Grünenthal develops new approaches to better understand disease mechanisms and address them with targeted therapies.

Grünenthal applies its scientific strengths not only to pain but to adjacent therapeutic areas where similar pathophysiological processes play a role. This approach creates opportunities to transfer research insights into additional disease areas and, ultimately, help more people worldwide. 

Our approach to pain R&D

Research & Development is dedicated to identifying, exploring and advancing innovative therapies for diseases with a high unmet medical need. At the heart of this is scientific excellence, cross-functional collaboration and a strong commitment to translate new therapeutic approaches into real-world impact.

A particular focus is on understanding the biological mechanisms behind pain and related diseases. Based on our industry-leading expertise in the pathophysiology of pain, sensory biology and neuronal health, Grünenthal develops new approaches to better understand disease mechanisms and address them with targeted therapies.

Grünenthal applies its scientific strengths not only to pain but to adjacent therapeutic areas where similar pathophysiological processes play a role. This approach creates opportunities to transfer research insights into additional disease areas and, ultimately, help more people worldwide. 

 

Therapeutic areas in focus

Our teams in Research & Development work with a holistic and science-driven approach. They identify promising targets, evaluate new compounds and assess whether existing substances may be suitable for additional indications. At the same time, our experts collaborate closely with external partners from across academia and industry, and we expand our R&D pipeline through the targeted acquisition of innovative assets.

Our interdisciplinary way of working makes the R&D division particularly exciting for people who strive to combine innovation, teamwork and scientific excellence in their new role.

The departments within R&D

Our Research team takes a technology-agnostic approach to drive innovative solutions for patients. They identify and validate targets, and through translational research, our experts continually deepen our understanding of the underlying diseases. Building on this, we make targeted use of various modalities and platforms to achieve the best possible outcomes for patients, including genetic medicine platforms, with a special emphasis on RNA-based therapeutic approaches.  

The experts in our Development team contribute their expertise in Clinical Science, Data Science, Development Operations, Advanced Analytics, and Chemistry, Manufacturing and Controls (CMC). They understand the medical and pharmaceutical science behind new compounds, know how to transform data into meaningful information for efficient decision-making and deliver on our clinical strategies. 

The Program Management & Information Management group helps us drive our programmes forward, focusing on speed, value and cost, while providing key information systems for our Research and Development area.  

Our Drug Safety department puts patients at the centre of everything it does. The team ensures patient safety for Grünenthal’s brands worldwide and has representatives in all Grünenthal affiliates and at our headquarters in Aachen, Germany. The team is involved in all phases of a product’s life cycle and leverage its deep medical and pharmaceutical expertise, as well as its knowledge of international and national guidelines. 

Our Regulatory Affairs department brings together passionate, highly skilled and experienced colleagues who are located across various countries and regions. They develop fit-for-purpose regulatory strategies to successfully secure marketing authorisations for our investigational medicines and accompany products through their entire life-cycle.  

Meet our scientists

Keith Philips, Head of Genetic Medicine

Helps drive our RNA-based research programmes and develops our Genetic Medicine platform, exploring innovative scientific approaches and technologies that could lead to new treatment options and make a meaningful difference to patients.


Science Made Me...leveraging genetic medicine to help patients

Sevil Davidson, Computational Biologist

Leverages AI and machine learning to analyse complex scientific data, uncover meaningful insights and accelerate the identification of promising therapeutic candidates, supporting research into innovative treatment options for patients.


Science Made Me...develop algorithms that can design innovative molecules

Chanchal Kumar, Head, Bioinformatics, Disease Understanding

Fascinated by the opportunities of single-cell omics and the potential to turn vast amounts of data into knowledge that may deepen our understanding of pain and, ultimately, contribute to the creation of innovative treatment options.


Science Made Me...leveraging single-cell approaches in pain research

Maria Stupar, Global Safety Lead

Ensures that we maintain the highest safety standards for our products, using data-driven insights to support informed decisions and remain a trusted partner for healthcare professionals and the patients we serve.


Science Made Me...discover the power of data to ensure patient safety

Florian Jakob, Head of Drug Discovery Engine

Grown at Grünenthal from an early-career researcher into his current role. Excited by the idea of taking a tiny molecule and designing it to have a very specific, positive effect for patients, he pursues tomorrow’s innovations.


Science Made Me...seek big challenges with the potential to change patients' lives

Ready to apply?

Ready to apply?

Ready to apply?